Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

J. Martin-Broto, S. Stacchiotti, A. Lopez-Pousa, A. Redondo, D. Bernabeu, E. de Alava, P.G. Casali, A. Italiano, A. Gutierrez, D.S. Moura, M. Peña-Chilet, J. Diaz-Martin, M. Biscuola, M. Taron, P. Collini, D. Ranchere-Vince, X. Garcia del Muro, G. Grignani, S. Dumont, J. Martinez-TruferoE. Palmerini, N. Hindi, A. Sebio, J. Dopazo, A.P. Dei Tos, A. LeCesne, J.-Y. Blay, J. Cruz

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)134-144
Number of pages11
JournalThe Lancet Oncology
Volume20
Issue number1
DOIs
Publication statusPublished - 2019

Cite this

Martin-Broto, J., Stacchiotti, S., Lopez-Pousa, A., Redondo, A., Bernabeu, D., de Alava, E., Casali, P. G., Italiano, A., Gutierrez, A., Moura, D. S., Peña-Chilet, M., Diaz-Martin, J., Biscuola, M., Taron, M., Collini, P., Ranchere-Vince, D., Garcia del Muro, X., Grignani, G., Dumont, S., ... Cruz, J. (2019). Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial. The Lancet Oncology, 20(1), 134-144. https://doi.org/10.1016/S1470-2045(18)30676-4